| Identification | Back Directory | [Name]
Piperidine,3,4,5-tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-,(2R,3R,4R,5S)- | [CAS]
69567-11-9 | [Synonyms]
Deoxynojirimycin Tetrabenzyl Ether
2,3,4,6-Tetra-O-benzyl-(+)-1-deoxynojirimycin
Deoxynojirimycin Tetrabenzyl Ether Exclusive
3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine
3,4,5-tris(benzyloxy)-2-((benzyloxy)methyl)piperidine(WXC06522)
Piperidine,3,4,5-tris(phenylmethoxy)-2-[(phenylmethoxy)methyl]-,(2R,3R,4R,5S)- | [Molecular Formula]
C34H37NO4 | [MOL File]
69567-11-9.mol | [Molecular Weight]
523.66 |
| Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 15 mg/ml; DMSO: 20 mg/ml; DMSO:PBS(pH7.2) 1:1: 0.5 mg/ml; Ethanol: 0.25 mg/ml | [form ]
A crystalline solid |
| Hazard Information | Back Directory | [Description]
Deoxynojirimycin (dNM) tetrabenzyl ether is an intermediate for the synthesis of glucosylceramide synthase inhibitors such as 1-dNM, a glucose analog that potently inhibits α-glucosidase I and II.1 | [Uses]
Deoxynojirimycin tetrabenzyl ether (compound 2) is an inhibitor of hBuChE with IC50 value of 2.0 μM[1]. | [storage]
Store at -20°C | [References]
1. Matos, C.R.R., Lopes, R.S.C., and Lopes, C.C. Synthesis of 1-deoxynojirimycin and N-butyl-1-deoxynojirimycin Synthesis 4,571-573(1999). |
|
| Company Name: |
Wuxi AppTec
|
| Tel: |
022-59987777 13552403979 |
| Website: |
www.labnetwork.com |
|